Download PDF
Journal of Pediatric Neurology 2022; 20(05): 319-326
DOI: 10.1055/s-0042-1751264
Review Article

Nonvascular Nervous System Complications in Pediatric Patients with COVID-19 Infection

Figen Palabiyik
1   Department of Radiology, University of Texas Southwestern Medical Center and Children's Health, Dallas, Texas, United States
,
Korgün Koral
2   Department of Pediatric Radiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
,
Sumit Pruthi
3   Radiology and Pediatrics, Department of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee, United States
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Coronavirus disease (COVID-19) is caused by a novel severe acute respiratory syndrome coronavirus 2 virus which primarily targets the lungs. However, the central nervous system (CNS) and peripheral nervous system involvement due to COVID-19, however, has been reported as early as the cases of respiratory system involvement. In addition, there have been many reports describing neuroimaging features of COVID-19, but data beyond case studies in the pediatric population are still limited, indicating limited CNS involvement. The CNS involvement and complications include, but are not limited to, encephalopathy, meningoencephalitis, ischemic stroke, venous sinus thrombosis, acute necrotizing encephalopathy, acute disseminated encephalomyelitis, posterior reversible encephalopathy syndrome, acute cerebellitis, acute hemorrhagic myelitis, and Guillain–Barré syndrome. In this manuscript, we will discuss the imaging characteristics of some of these entities with a known diagnosis of COVID-19.

Keywords

COVID-19 - central nervous system - peripheral nervous system


Publication History

Received: 01 June 2022

Accepted: 01 June 2022

Article published online:
24 August 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Helms J, Kremer S, Merdji H. et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020; 382 (23) 2268-2270
    CrossrefPubMedGoogle Scholar
  • 2 Moriguchi T, Harii N, Goto J. et al. A first case of meningitis/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis 2020; 94: 55-58
    CrossrefPubMedGoogle Scholar
  • 3 Beyrouti R, Adams ME, Benjamin L. et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry 2020; 91 (08) 889-891
    CrossrefPubMedGoogle Scholar
  • 4 Beslow LA, Linds AB, Fox CK. et al; International Pediatric Stroke Study Group. Pediatric ischemic stroke: an infrequent complication of SARS-CoV-2. Ann Neurol 2021; 89 (04) 657-665
    CrossrefPubMedGoogle Scholar
  • 5 Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology 2020; 296 (02) E119-E120
    CrossrefPubMedGoogle Scholar
  • 6 Parsons T, Banks S, Bae C, Gelber J, Alahmadi H, Tichauer M. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol 2020; 267 (10) 2799-2802
    CrossrefPubMedGoogle Scholar
  • 7 Arslan G, Besci T, Karaca Ö, Aylan Gelen S. Posterior reversible encephalopathy syndrome related to COVID-19 in a child. Pediatr Int (Roma) 2022; 64 (01) e14908
    PubMedGoogle Scholar
  • 8 Korkmazer B, Ozogul M, Hikmat E. et al. Posterior reversible encephalopathy syndrome in a pediatric COVID-19 patient. Pediatr Infect Dis J 2021; 40 (06) e240-e242
    CrossrefPubMedGoogle Scholar
  • 9 Sotgiu S, Uzzau S, Pippia A, Carta A, Antonucci R. Expanding the spectrum of acute cerebellitis due to SARS-Cov-2. Pediatr Neurol 2021; 121: 1-2
    CrossrefPubMedGoogle Scholar
  • 10 Maghrabi Y, Baeesa SS. Acute hemorrhagic myelitis in an adolescent with COVID-19: a case report and review of literature. Cureus 2021; 13 (12) e20553
    PubMedGoogle Scholar
  • 11 Toscano G, Palmerini F, Ravaglia S. et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med 2020; 382 (26) 2574-2576
    CrossrefPubMedGoogle Scholar
  • 12 Bodro M, Compta Y, Sanchez-Valle R. Presentations and mechanisms of CNS disorders related to COVID-19. Neurol Neuroimmunol Neuroinflamm 2021; 8 (01) e923
    CrossrefPubMedGoogle Scholar
  • 13 Lindan CE, Mankad K, Ram D, Kociolek LK, Silvera VM, Boddaert N. et al. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health 2021; 5 (03) 167-177
    CrossrefPubMedGoogle Scholar
  • 14 Sarbu N, Shih RY, Jones RV, Horkayne-Szakaly I, Oleaga L, Smirniotopoulos JG. White matter diseases with radiologic-pathologic correlation. Radiographics 2016; 36 (05) 1426-1447
    CrossrefPubMedGoogle Scholar
  • 15 Varadan B, Shankar A, Rajakumar A. et al. Acute hemorrhagic leukoencephalitis in a COVID-19 patient-a case report with literature review. Neuroradiology 2021; 63 (05) 653-661
    CrossrefPubMedGoogle Scholar
  • 16 Grzonka P, Scholz MC, De Marchis GM. et al. Acute hemorrhagic leukoencephalitis: a case and systematic review of the literature. Front Neurol 2020; 11: 899
    CrossrefPubMedGoogle Scholar
  • 17 Atherton DS, Perez SR, Gundacker ND, Franco R, Han X. Acute disseminated encephalomyelitis presenting as a brainstem encephalitis. Clin Neurol Neurosurg 2016; 143: 76-79
    CrossrefPubMedGoogle Scholar
  • 18 Fink EL, Robertson CL, Wainwright MS. et al; Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID) Investigators. Prevalence and risk factors of neurologic manifestations in hospitalized children diagnosed with acute SARS-CoV-2 or MIS-C. Pediatr Neurol 2022; 128: 33-44
    CrossrefPubMedGoogle Scholar
  • 19 Agarwal S, Conway J, Nguyen V. et al. Serial imaging of virus-associated necrotizing disseminated acute leukoencephalopathy (VANDAL) in COVID-19. AJNR Am J Neuroradiol 2021; 42 (02) 279-284
    CrossrefPubMedGoogle Scholar
  • 20 de Miranda Henriques-Souza AM, de Melo ACMG, de Aguiar Coelho Silva Madeiro B, Freitas LF, Sampaio Rocha-Filho PA, Gonçalves FG. Acute disseminated encephalomyelitis in a COVID-19 pediatric patient. Neuroradiology 2021; 63 (01) 141-145
    CrossrefPubMedGoogle Scholar
  • 21 Akçay N, Bektaş G, Menentoğlu ME. et al. COVID-19-associated acute disseminated encephalomyelitis-like disease in 2 children. Pediatr Infect Dis J 2021; 40 (11) e445-e450
    CrossrefPubMedGoogle Scholar
  • 22 Palabiyik F, Akcay N, Sevketoglu E, Hatipoglu N, Sari EE, Inci E. Imaging of multisystem inflammatory disease in children (MIS-C) associated with COVID-19. Acad Radiol 2021; 28 (09) 1200-1208
    CrossrefPubMedGoogle Scholar
  • 23 Lindan CE, Mankad K, Ram D. et al; ASPNR PECOBIG Collaborator Group. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health 2021; 5 (03) 167-177
    CrossrefPubMedGoogle Scholar
  • 24 Siracusa L, Cascio A, Giordano S. et al. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature. Ital J Pediatr 2021; 47 (01) 123
    CrossrefPubMedGoogle Scholar
  • 25 Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK. Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following COVID-19: systematic review and meta-synthesis. Neurol Neuroimmunol Neuroinflamm 2021; 8 (06) e1080
    CrossrefPubMedGoogle Scholar
  • 26 McLendon LA, Rao CK, Da Hora CC, Islamovic F, Galan FN. Post-COVID-19 acute disseminated Encephalomyelitis in a 17-month-old. Pediatrics 2021; 147 (06) e2020049678
    CrossrefPubMedGoogle Scholar
  • 27 Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 2015; 14 (09) 914-925
    CrossrefPubMedGoogle Scholar
  • 28 Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008; 65 (02) 205-210
    PubMedGoogle Scholar
  • 29 Strandgaard S, Olesen J, Skinhoj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. BMJ 1973; 1 (5852): 507-510
    CrossrefPubMedGoogle Scholar
  • 30 Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008; 29 (06) 1043-1049
    CrossrefPubMedGoogle Scholar
  • 31 Colombo A, Martinelli Boneschi F, Beretta S. et al. Posterior reversible encephalopathy syndrome and COVID-19: a series of 6 cases from Lombardy, Italy. eNeurologicalSci 2020; 22: 100306
    CrossrefPubMedGoogle Scholar
  • 32 Iftikhar S, Rehman AU, Ameer MZ. et al. The association of posterior reversible encephalopathy syndrome with COVID-19: a systematic review. Ann Med Surg (Lond) 2021; 72: 103080
    CrossrefPubMedGoogle Scholar
  • 33 Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol 2021; 93 (01) 250-256
    CrossrefPubMedGoogle Scholar
  • 34 Kontzialis M, Soares BP, Huisman TAGM. Lesions in the splenium of the corpus callosum on MRI in children: a review. J Neuroimaging 2017; 27 (06) 549-561
    CrossrefPubMedGoogle Scholar
  • 35 Bektaş G, Akçay N, Boydağ K, Şevketoğlu E. Reversible splenial lesion syndrome associated with SARS-CoV-2 infection in two children. Brain Dev 2021; 43 (02) 230-233
    CrossrefPubMedGoogle Scholar
  • 36 Edjlali M, Le Gal A, Louvet M. et al; Garches COVID-19 Collaborative Group. Teaching NeuroImages: cytotoxic lesions of the corpus callosum in encephalopathic patients with COVID-19. Neurology 2020; 95 (22) 1021-1022
    CrossrefPubMedGoogle Scholar
  • 37 DE Oliveira FAA, DE Melo TFB, Rocha-Filho PAS. FAA DEO. Transient lesion in the splenium of the corpus callosum associated with COVID-19. Arq Neuropsiquiatr 2020; 78 (11) 738
    Article in Thieme ConnectPubMedGoogle Scholar
  • 38 Forestier G, de Beaurepaire I, Bornet G, Boulouis G. Cytotoxic lesion of the corpus callosum as presenting neuroradiological manifestation of COVID-2019 infection. J Neurol 2021; 268 (05) 1595-1597
    CrossrefPubMedGoogle Scholar
  • 39 Caress JB, Castoro RJ, Simmons Z. et al. COVID-19-associated Guillain-Barré syndrome: the early pandemic experience. Muscle Nerve 2020; 62 (04) 485-491
    CrossrefPubMedGoogle Scholar
  • 40 Jacobs BC, Rothbarth PH, van der Meché FG. et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 1998; 51 (04) 1110-1115
    CrossrefPubMedGoogle Scholar
  • 41 Haber P, DeStefano F, Angulo FJ. et al. Guillain-Barré syndrome following influenza vaccination. JAMA 2004; 292 (20) 2478-2481
    CrossrefPubMedGoogle Scholar
  • 42 Akçay N, Menentoğlu ME, Bektaş G, Şevketoğlu E. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child. J Med Virol 2021; 93 (09) 5599-5602
    CrossrefPubMedGoogle Scholar
  • 43 McKean N, Chircop C. Guillain-Barré syndrome after COVID-19 vaccination. BMJ Case Rep 2021; 14 (07) e244125
    CrossrefPubMedGoogle Scholar
  • 44 Sadeghizadeh A, Pourmoghaddas Z, Zandifar A. et al. Reversible cerebral vasoconstriction syndrome and multisystem inflammatory syndrome in children with COVID-19. Pediatr Neurol 2022; 129: 1-6
    CrossrefPubMedGoogle Scholar